Therapeutic Advances in Biological Response Modifiers in the Treatment of Cutaneous T-Cell Lymphoma

By Vittorio C.C.   Rook A.H.   French L.E.   Shapiro M.   Lehrer M.S.   Junkinshopkins J.M.  

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 431-437

Adis International

Access to resources Recommend Favorite

Current Status and Future Directions of Gene and Cell Therapy for Cystic Fibrosis

By Griesenbach Uta   Alton Eric W.F.W.  

BioDrugs, Vol. 25, Iss. 2, 2011-04 ,pp. : 77-88

Adis International

Access to resources Recommend Favorite

Teledermatology: Current Status and Future Directions

By Whited J.D.  

American Journal of Clinical Dermatology, Vol. 2, Iss. 2, 2001-02 ,pp. : 59-64

Adis International

Access to resources Recommend Favorite

Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma

By Lyseng-Williamson Katherine A.   Yang Lily P.H.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite

Management of Refractory Early-Stage Cutaneous T-Cell Lymphoma

By Huber Margit A.  

American Journal of Clinical Dermatology, Vol. 7, Iss. 3, 2006-01 ,pp. : 155-169

Adis International

Access to resources Recommend Favorite